Benefits of collaborative care for post-CABG depression are not related to adjustments in antidepressant pharmacotherapy

Journal of Psychosomatic Research

Volumn 76, Issue 1, 2014, Pages 28-33

  Meyer, Thomas ^a   Belnap, Bea Herbeck ^b   Herrmann Lingen, Christoph ^a   He, Fanyin ^c   Mazumdar, Sati ^c   Rollman, Bruce L ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antidepressant pharmacotherapy; Collaborative care; Coronary artery bypass surgery; Depression; Health related quality of life

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS SURGERY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; MIDDLE AGED; PATIENT REFERRAL; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; SHORT FORM 36; TREATMENT RESPONSE;

ANTIDEPRESSANT PHARMACOTHERAPY; COLLABORATIVE CARE; CORONARY ARTERY BYPASS SURGERY; DEPRESSION; HEALTH-RELATED QUALITY OF LIFE;

ADAPTATION, PSYCHOLOGICAL; AFFECT; AGED; ANTIDEPRESSIVE AGENTS; BIBLIOTHERAPY; COOPERATIVE BEHAVIOR; CORONARY ARTERY BYPASS; DEPRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; QUALITY OF LIFE; REFERRAL AND CONSULTATION; WATCHFUL WAITING;

EID: 84890803959     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.10.017     Document Type: Article

References (36)

1. Magni G, Unger HP, Valfrè C, Polesel E, Cesari F, Rizzardo R, et al. Psychosocial outcome one year after heart surgery. A prospective study. Arch Intern Med 1987, 147:473-477.
2. Vingerhoets G Perioperative anxiety and depression in open-heart surgery. Psychosomatics 1998, 39:30-37.
3. Goyal TM, Idler EL, Krause TJ, Contrada RJ Quality of life following cardiac surgery: impact of the severity and course of depressive symptoms. Psychosom Med 2005, 67:759-765.
4. Oxlad M, Stubberfield J, Stuklis R, Edwards J, Wade TD Psychological risk factors for cardiac-related hospital readmission within 6months of coronary artery bypass graft surgery. J Psychosom Res 2006, 61:775-781.
5. Morone NE, Weiner DK, Herbeck Belnap B, Karp JF, Mazumdar S, Houck PR, et al. The impact of pain and depression on recovery after coronary artery bypass grafting. Psychosom Med 2010, 72:620-625.
6. Baker RA, Andrew MJ, Schrader G, Knight JL Preoperative depression and mortality in coronary artery bypass surgery: preliminary findings. ANZ J Surg 2001, 71:139-142.
7. Burg MM, Benedetto MC, Soufer R Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med 2003, 65:508-510.
8. Beresnevait́ M, Benetis R, Taylor GJ, Juŕnień K, Kinduris Š, Barauskień V Depression predicts perioperative outcomes following coronary artery bypass graft surgery. Scand Cardiovasc J 2010, 44:289-294.
9. Connerney I, Sloan RP, Shapiro PA, Bagiella E, Seckman C Depression is associated with increased mortality 10years after coronary artery bypass surgery. Psychosom Med 2010, 72:874-881.
10. Xiong GL, Jiang W, Clare R, Shaw LK, Smith PK, Mahaffey KW, et al. Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am J Cardiol 2006, 98:42-47.
11. Rollman BL, Herbeck Belnap B, LeMenager MS, Mazumdar S, Schulberg HC, Reynolds CF The Bypassing the Blues treatment protocol: stepped collaborative care for treating post-CABG depression. Psychosom Med 2009, 71:217-230.
12. Rollman BL, Herbeck Belnap B, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, et al. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA 2009, 302:2095-2103.
13. Kroenke K, Spitzer RL, Williams JB The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003, 41:1284-1292.
14. Kroenke K, Spitzer RL, Williams JB The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613.
15. McManus D, Pipkin SS, Whooley MA Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol 2005, 96:1076-1081.
16. Katon W, Ludman E, Simon S The depression helpbook 2002, Bull Publishing, Boulder, CO.
17. Ware J, Kosinski M, Keller S SF-36 physical and mental health summary scales: A user's manual 1994, New England Medical Center, Boston. 2nd ed.
18. Watson EK, Firman DW, Baade PD, Ring I Telephone administration of the SF-36 health survey: validation studies and population norms for adults in Queensland. Aust N Z J Public Health 1996, 20:359-363.
19. Freedland KE, Skala JA, Carney RM, Raczynski JM, Taylor CB, Mendes de Leon CF, et al. The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med 2002, 64:897-905.
20. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989, 64:651-654.
21. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701-709.
22. Joynt KE, O'Connor CM Lessons from SADHART, ENRICHD, and other trials. Psychosom Med 2005, 67:S63-S66.
23. Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006, 63:283-288.
24. Swenson JR, O'Connor CM, Barton D, van Zyl LT, Swedberg K, Forman LM, et al. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003, 92:1271-1276.
25. O'Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010, 56:692-699.
26. Frasure-Smith N, Koszycki D, Swenson JR, Baker B, van Zyl LT, Laliberté MA, et al. Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE). Psychosom Med 2006, 68:87-93.
27. Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007, 297:367-379.
28. Gottlieb SS, Kop WJ, Thomas SA, Katzen S, Vesely MR, Greenberg N, et al. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. Am Heart J 2007, 153:868-873.
29. Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, et al. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms. Contemp Clin Trials 2009, 30:205-211.
30. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003, 289:3106-3116.
31. Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney RM, Burg MM, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005, 62:792-798.
32. Glassman AH, Bigger JT Antidepressants in coronary heart disease: SSRIs reduce depression, but do they save lives?. JAMA 2007, 297:411-421.
33. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008, 5:e45.
34. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010, 303:47-53.
35. Huffman JC, Mastromauro CA, Sowden G, Fricchione GL, Healy BC, Januzzi JL Impact of a depression care management program for hospitalized cardiac patients. Circ Cardiovasc Qual Outcomes 2011, 4:198-205.
36. Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 2010, 170:600-608.